Skip to main navigation Skip to search Skip to main content

SBIR: Testing Efficacy, Pharmacodynamic and Pharmacokinetic of New Immunotherapeutic Drug for Ovarian and Melanoma Cancer

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/21 → 09/30/22

Funding

  • National Cancer Institute: $96,748.00